Eventide Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-30,900
| Closed | -$14.9M | – | 172 |
|
|
2020
Q4 | $14.9M | Hold |
30,900
| – | – | 0.23% | 97 |
|
|
2020
Q3 | $17.3M | Hold |
30,900
| – | – | 0.34% | 82 |
|
|
2020
Q2 | $19.3M | Hold |
30,900
| – | – | 0.42% | 70 |
|
|
2020
Q1 | $15.1M | Buy |
+30,900
| New | +$15.1M | 0.49% | 63 |
|
|
2018
Q4 | – | Sell |
-23,000
| Closed | -$9.29M | – | 147 |
|
|
2018
Q3 | $9.29M | Hold |
23,000
| – | – | 0.34% | 79 |
|
|
2018
Q2 | $7.94M | Hold |
23,000
| – | – | 0.33% | 79 |
|
|
2018
Q1 | $7.92M | Buy |
23,000
+15,500
| +207% | +$5.34M | 0.37% | 74 |
|
|
2017
Q4 | $2.82M | Hold |
7,500
| – | – | 0.15% | 97 |
|
|
2017
Q3 | $3.35M | Hold |
7,500
| – | – | 0.19% | 87 |
|
|
2017
Q2 | $3.68M | Buy |
+7,500
| New | +$3.68M | 0.23% | 81 |
|